-+ 0.00%
-+ 0.00%
-+ 0.00%

Amylyx Pharmaceuticals Advances AMX0318 as Long-Acting GLP-1 Receptor Antagonist for Rare Diseases

Reuters·01/08/2026 12:00:45

Please log in to view news